News Quantified

ALEC – alector, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Alector to Participate in the Bank of America CNS Therapeutics Conference [Yahoo! Finance]

Alector to Participate in the Bank of America CNS Therapeutics Conference

ALEC Investors Have Opportunity to Join Alector, Inc. Fraud Investigation with the Schall Law Firm

ALEC Investors Have Opportunity to Join Alector, Inc. Fraud Investigation with the Schall Law Firm

ALEC Investors Have Opportunity to Join Alector, Inc. Fraud Investigation with the Schall Law Firm

-1.5%

BEAT

47.3%

BEAT

-3.5%

BEAT

-3.5%

BEAT

Form 4 Alector, Inc. For: Dec 03 Filed by: Wong-Sarad Grace

Form 4 Alector, Inc. For: Dec 03 Filed by: Kenkare-Mitra Sara

Form 4 Alector, Inc. For: Dec 03 Filed by: Rosenthal Arnon

Form 4 Alector, Inc. For: Dec 03 Filed by: Berkley Neil Lindsay

Form 144 Alector, Inc. Filed by: Rosenthal Arnon

Top News Gainers

2/5 Alector Announces FDA Fast Track Designation Granted to AL101 for the Treatment of Patients with Frontotemporal Dementia 12.0%

1/30 Form EFFECT Alector, Inc. 10.9%

1/8 Alector to Present at the J.P. Morgan 38th Annual Healthcare Conference 10.0%

4/28 Alector Inc (NASDAQ: ALEC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 8.9%

4/17 Form SC 13D/A Alector, Inc. Filed by: ORBIMED ADVISORS LLC 8.0%

2/3 Alector Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 7.1%

5/13 Q1/2019 3/31/2019 EPS -0.420 ZacksConsensus N/A ActVsEst N/A - N/A 6.2%

3/25 Alector Enters into a Licensing Agreement with Innovent Biologics to Develop and Commercialize AL008 in Oncology Indications in China 5.5%

9/9 Alector Initiates Phase 2 Trial of AL001 in Patients with Frontotemporal Dementia 4.7%

12/11 Alector Announces Appointment of Shehnaaz Suliman, M.D., MBA, M.Phil., as President and Chief Operating Officer 4.3%

Top News Decliners

3/30 Form 144 Alector, Inc. Filed by: ORBIMED ADVISORS LLC -22.2%

2/7 Form 4 Alector, Inc. For: Feb 05 Filed by: Paul Robert -19.8%

3/23 Alector Announces the Appointment of Paula Hammond, Ph.D., to the Board of Directors -18.8%

3/17 Alector Inc (NASDAQ: ALEC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $26.00 price target on the stock. -11.1%

2/24 Alector to Present at the Cowen 40th Annual Health Care Conference -11.0%

4/2 Form 4 Alector, Inc. For: Mar 31 Filed by: ORBIMED ADVISORS LLC -8.8%

4/9 Form 144 Alector, Inc. Filed by: ORBIMED ADVISORS LLC -8.0%

12/8 Alector Inc (NASDAQ: ALEC) had its "buy" rating re-affirmed by analysts at Cowen Inc. -6.2%

3/4 Form 4 Alector, Inc. For: Mar 02 Filed by: OrbiMed Capital GP IV LLC -6.0%

1/27 Alector Announces Proposed Public Offering of Common Stock -5.4%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day